Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lyfe Rx vs Rejuve Meds

Lyfe Rx
Graded #375

Lower grade

vs+7.5
Rejuve Meds
Graded #217

Higher grade

The verdict

Rejuve Meds takes it — 65.8/100 to 58.3/100.

Rejuve Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRejuve Meds +14
50
64
Dose & formulationEven
64
64
Clinical oversightRejuve Meds +12
67
79
Labs & monitoringEven
52
52
FulfillmentRejuve Meds +9
62
71
Contract termsRejuve Meds +6
55
61
Lyfe Rx · left barRejuve Meds · right bar

The numbers

MetricLyfe RxRejuve Meds
WeighScore58.3/10065.8/100
GradeCC
Scorecard rank#375#217
Semaglutide$225/mo (compounded)$165/mo (starting dose, compounded)
Tirzepatide$299/mo (compounded)$265/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lyfe Rx

Graded #375 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued this company a warning letter dated 9 September 2025; the letter is public in FDA's warning-letter database
Rejuve Meds

Graded #217 · C

Strengths

  • Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
  • No membership fees — everything is included; free shipping
  • HSA/FSA eligible; intro pricing from $85 for the first month
  • Doctor-guided programs with personalized care
  • Names a "Rejuve Meds Pharmacy Network" for fulfillment

Where it loses points

  • Individual compounding pharmacies not named (only a "pharmacy network")
  • Prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard